Ignite Creation Date:
2025-12-25 @ 3:09 AM
Ignite Modification Date:
2026-03-12 @ 1:55 PM
Study NCT ID:
NCT02501005
Status:
TERMINATED
Last Update Posted:
2019-07-08
First Post:
2015-07-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Preventive aBlation of vEntricular tachycaRdia in Patients With myocardiaL INfarction
Sponsor:
Biotronik SE & Co. KG
Organization:
Study Overview
Official Title:
Preventive aBlation of vEntricular tachycaRdia in Patients With myocardiaL INfarction
Status:
TERMINATED
Status Verified Date:
2019-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
The study was stopped due to futility
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
BERLIN VT
Brief Summary:
The BERLIN VT study is designed to evaluate the impact of prophylactic ventricular tachycardia (VT) ablation on all-cause mortality and unplanned hospital admission for congestive heart failure or symptomatic ventricular tachycardia/ventricular fibrillation (VF) when compared to VT ablation after the third appropriate implantable cardioverter-defibrillator (ICD) shock.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: